Morgan Stanley
EVFM

Morgan Stanley’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Morgan Stanley’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-58,882
Closed -$66K – 8217
2022
Q2 		$66K Buy
58,882
+41,597
+241% +$68.6K ﹤0.01% 6487
2022
Q1 		$88K Buy
17,285
+6,050
+54% +$38K ﹤0.01% 6391
2021
Q4 		$63K Sell
11,235
-1,821
-14% -$15.5K ﹤0.01% 6704
2021
Q3 		$144K Sell
13,056
-262,268
-95% -$3.3M ﹤0.01% 6177
2021
Q2 		$4.67M Buy
275,324
+266,523
+3,028% +$5.05M ﹤0.01% 3851
2021
Q1 		$231K Buy
8,801
+2,008
+30% +$91.3K ﹤0.01% 5583
2020
Q4 		$246K Sell
6,793
-44,940
-87% -$1.62M ﹤0.01% 5488
2020
Q3 		$1.83M Sell
51,733
-151,909
-75% -$6.6M ﹤0.01% 3731
2020
Q2 		$8.64M Buy
203,642
+203,514
+158,995% +$13.7M ﹤0.01% 2099
2020
Q1 		$10K Sell
128
-1,322
-91% -$106K ﹤0.01% 6028
2019
Q4 		$134K Buy
1,450
+1,072
+284% +$90.5K ﹤0.01% 5562
2019
Q3 		$29K Buy
378
+352
+1,354% +$27K ﹤0.01% 5908
2019
Q2 		$2K Buy
26
+1
+4% +$77 ﹤0.01% 6492
2019
Q1 		$1K Hold
25
– – ﹤0.01% 6555
2018
Q4 		$1K Sell
25
-160
-86% -$8.8K ﹤0.01% 6545
2018
Q3 		$11K Buy
185
+182
+6,067% +$7.88K ﹤0.01% 6289
2018
Q2 		$0 Buy
+3
New +$236 ﹤0.01% 6797
2017
Q4 		– Sell
-11
Closed – – 6711
2017
Q3 		$0 Buy
+11
New +$425 ﹤0.01% 6661
2017
Q2 		– Sell
-58
Closed -$8K – 6691
2017
Q1 		$8K Sell
58
-11
-16% -$1.43K ﹤0.01% 6279
2016
Q4 		$7K Hold
69
– – ﹤0.01% 6235
2016
Q3 		$7K Sell
69
-2
-3% -$183 ﹤0.01% 6185
2016
Q2 		$6K Buy
71
+1
+1% +$90 ﹤0.01% 6194
2016
Q1 		$4K Sell
70
-1
-1% -$77 ﹤0.01% 6335
2015
Q4 		$9K Hold
71
– – ﹤0.01% 6272
2015
Q3 		$51K Buy
71
+25
+54% +$26.8K ﹤0.01% 5723
2015
Q2 		$37K Buy
+46
New +$29.5K ﹤0.01% 5966
2015
Q1 		– Sell
-25
Closed -$17K – 6712
2014
Q4 		$17K Buy
+25
New +$18.9K ﹤0.01% 6099

Other funds holding EVFM

CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Morgan Stanley's EVFM Position: Q3 2022 in Review

Morgan Stanley sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q3 2022, closing a stake of 58,882 shares — an estimated $66K sold.

Morgan Stanley first reported a position in EVFM in Q4 2014 and held it in 27 quarters. The position peaked at $8.64M in Q2 2020. 8 funds tracked by Wall St. Rank hold EVFM as of Q3 2022.

  • Morgan Stanley reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Morgan Stanley sold 58,882 Evofem Biosciences, Inc. Common Stock shares in Q3 2022, an estimated $66K.
  • Morgan Stanley first reported a position in Evofem Biosciences, Inc. Common Stock in Q4 2014 and held it in 27 quarters.
  • Morgan Stanley's Evofem Biosciences, Inc. Common Stock position peaked at $8.64M in Q2 2020.
  • 8 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q3 2022.

Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.